Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex  by Li, Vivian S.W. et al.
Wnt Signaling through Inhibition
of b-Catenin Degradation in
an Intact Axin1 Complex
Vivian S.W. Li,1,8 Ser Sue Ng,1,8 Paul J. Boersema,2,3,4 Teck Y. Low,2,3 Wouter R. Karthaus,1 Jan P. Gerlach,5
Shabaz Mohammed,2,3 Albert J.R. Heck,2,3 Madelon M. Maurice,5 Tokameh Mahmoudi,1,6,7,* and Hans Clevers1,7,*
1Hubrecht Institute, KNAW and University Medical Centre Utrecht, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands
2Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical
Sciences, Utrecht University, 3584 CH Utrecht, The Netherlands
3Netherlands Proteomics Centre, 3584 CH Utrecht, The Netherlands
4Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, AmKlopferspitz 18, 82152Martinsried, Germany
5Department of Cell Biology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
6Erasmus University Medical Center, Department of Biochemistry, 3000 CA Rotterdam, The Netherlands
7Centre for Biomedical Genetics, 3584 CG Utrecht, The Netherlands
8These authors contributed equally to this work
*Correspondence: t.mahmoudi@erasmusmc.nl (T.M.), h.clevers@hubrecht.eu (H.C.)
DOI 10.1016/j.cell.2012.05.002SUMMARY
Degradation of cytosolic b-catenin by the APC/Axin1
destruction complex represents the key regulated
step of the Wnt pathway. It is incompletely under-
stood how the Axin1 complex exerts its Wnt-regu-
lated function. Here, we examine the mechanism of
Wnt signaling under endogenous levels of the Axin1
complex. Our results demonstrate that b-catenin is
not only phosphorylated inside the Axin1 com-
plex, but also ubiquinated and degraded via the
proteasome, all within an intact Axin1 complex. In
disagreement with current views, we find neither a
disassembly of the complex nor an inhibition of
phosphorylation of Axin1-bound b-catenin upon
Wnt signaling. Similar observations are made in
primary intestinal epithelium and in colorectal cancer
cell lines carrying activating Wnt pathway mutations.
Wnt signaling suppresses b-catenin ubiquitination
normally occurring within the complex, leading to
complex saturation by accumulated phospho-b-
catenin. Subsequently, newly synthesized b-catenin
can accumulate in a free cytosolic form and engage
nuclear TCF transcription factors.
INTRODUCTION
The canonical Wnt (Wnt/b-catenin) signaling pathway controls
many biological processes, including cell fate determination,
cell proliferation, and stem cell maintenance (Clevers, 2006).
Deregulation of this pathway occurs in cancer and underlies
multiple hereditary syndromes (Clevers, 2006; MacDonald
et al., 2009). The key regulatory step involves the phosphoryla-tion, ubiquitination, and subsequent degradation of its down-
stream effector protein, b-catenin, by a dedicated cytoplasmic
destruction complex. This complex consists of the central scaf-
fold protein Axin and three other core components, adenoma-
tous polyposis coli (APC) and the kinases glycogen synthase
kinase-3 alpha/beta (GSK-3) and casein kinase-1 (CKI). Muta-
tions in components of the b-catenin destruction complex
(APC, AXIN, or b-catenin) result in cancer (Kinzler and Vogelstein,
1996; Korinek et al., 1997; Liu et al., 2000; Morin et al., 1997; Ru-
binfeld et al., 1996), most notably of the colon.
In resting cells, despite the gene being continuously tran-
scribed, vanishingly low levels of free b-catenin protein are
present in the cytosol. This pool of b-catenin is efficiently
captured by the destruction complex and phosphorylated by
CKI at Ser45, which in turn primes GSK3 phosphorylation of
b-catenin on the more N-terminal Thr41, Ser37, and Ser33 resi-
dues (Liu et al., 2002). Phosphorylated b-catenin is ubiquitinated
by the F-box-containing protein b-TrCP ubiquitin E3 ligase to
be degraded by the proteasome (Aberle et al., 1997; Kitagawa
et al., 1999).
Axin1 is the rate-limiting factor of the destruction complex (Lee
et al., 2003). Axin1 directly interacts with all other core compo-
nents of the destruction complex (b-catenin, APC, CKa, and
GSK3), thus being the central scaffold of the complex (Ikeda
et al., 1998; Kishida et al., 1998; Liu et al., 2002; Sakanaka
et al., 1998). As the least abundant component, Axin1 can regu-
late its rapid assembly and disassembly. For this reason, it has
been proposed that degradation of Axin1 in Wnt-activated cells
may be the immediate cause of b-catenin stabilization (Mao
et al., 2001; Tolwinski et al., 2003). Although multiple roles
have been proposed for the genetically essential APC protein,
there is no consensus as to its key activity.
Wnt ligands bind to the frizzled (FZD) and low-density-lipopro-
tein-related protein 5/6 (LRP5/6) coreceptor complex to activate
the canonical Wnt signaling pathway. Through an incompletelyCell 149, 1245–1256, June 8, 2012 ª2012 Elsevier Inc. 1245
resolved mechanism that involves Dishevelled, the activated
receptor complex disrupts or functionally inactivates the
destruction complex, leading to the accumulation and nuclear
translocation of b-catenin. In the nucleus, b-catenin engages
TCF/LEF transcription factors to activate the Wnt transcriptional
program (Molenaar et al., 1996; Behrens et al., 1996).
Several models describe the events following Wnt receptor
activation that lead to stabilization of b-catenin.
Membrane Sequestration of Axin1-GSK3
Sequestration of Axin1 by binding LRP5/6 reduces the avail-
ability of cytoplasmic destruction complexes, thereby causing
b-catenin accumulation. Membrane translocation of Axin1 may
also mediate its Wnt-induced dephosphorylation and destabili-
zation (Mao et al., 2001; Zeng et al., 2005).
Axin1 Degradation
Mediated by activated Wnt receptors or Dishevelled (Lee et al.,
2003; Mao et al., 2001; Tolwinski et al., 2003). Also, the poly-
ADP-ribosylating enzyme tankyrase can mediate Axin1 degra-
dation (Huang et al., 2009). By contrast, SUMOylation of Axin1
was reported to protect it from polyubiquitination and increase
its stability (Kim et al., 2008). An endocytic adaptor protein
Dab2 prevents Axin1 membrane translocation, thereby leading
to Axin1 stabilization (Jiang et al., 2009).
Dissociation of Axin1 and/or APC from GSK3
or b-Catenin
Dishevelled, which binds Axin1 directly, may disrupt the destruc-
tion complex upon Wnt activation (Liu et al., 2005; Logan and
Nusse, 2004; Malbon and Wang, 2006). Alternatively, Frat/GBP
family members may compete with Axin1 for GSK3 binding,
thus disrupting the destruction complex (van Amerongen and
Berns, 2005; van Amerongen et al., 2005). CKI and GSK3 can
phosphorylate Axin1 and APC, enhancing their binding affinity
for GSK3 and b-catenin. Wnt stimulation results in dephosphor-
ylation of both Axin1 and APC. The catalytic subunits of the
phosphatases PP1 and PP2A directly bind and dephosphorylate
Axin1, promoting the disassembly of the destruction complex
(Luo et al., 2007; Strovel et al., 2000).
Inhibition of GSK3 Kinase Activity
In vitro phosphorylation of b-catenin by GSK3 is inhibited by
PPPSPxS motif peptides or by phosphorylated LRP6 cyto-
plasmic domain (Cselenyi et al., 2008; Piao et al., 2008; Wu
et al., 2009). In addition, suppression of GSK3 kinase activity
by protein kinase B (PKB) directly or through Dishevelled may
mediate Wnt signal transduction (Desbois-Mouthon et al.,
2001; Fukumoto et al., 2001).
Dephosphorylation of Phosphorylated b-Catenin
CKIa/GSK3-phosphorylated b-catenin can be dephosphory-
lated by phosphatase PP2A uponWnt induction (Su et al., 2008).
GSK3 Sequestration
Taelman et al. propose that sequestration of GSK3 from the
cytosol into multivesicular bodies inhibits GSK3 activity during
Wnt signal transduction (Taelman et al., 2010).1246 Cell 149, 1245–1256, June 8, 2012 ª2012 Elsevier Inc.Complex Disassembly
Roberts et al. suggest that disassembly of the destruction
complex by APC through transferring phosphorylated b-catenin
to the E3 ligase recycles the destruction complex for renewed
b-catenin phosphorylation and degradation (Roberts et al.,
2011).
Thus, all previously proposedmodels (MacDonald et al., 2009)
either assume a physical dissociation of the b-catenin destruc-
tion complex or propose an interference with b-catenin phos-
phorylation, leading to stabilization of b-catenin. All studies cited
above, however, utilize overexpression strategies. Studies on
the endogenous complex are hampered by the fact that Axin1
is expressed at vanishingly low levels, whereas APC, CK1, and
GSK3, as well as b-catenin, occur abundantly outside of the
destruction complex. Here, we study the endogenous destruc-
tion complex during Wnt signaling.
RESULTS
b-Catenin Stabilization and Wnt Target Gene
Transcription Precede Axin Degradation
HEK293T cells carry an intact Wnt signaling cascade. We previ-
ously generated high-affinity immunoprecipitating (IP)/western
blotting monoclonal antibodies against Axin1 (Ng et al., 2009).
Pooled HEK293T cells from two 15 cm culture dishes allow visu-
alization of endogenous Axin1 in a single lane bywestern blotting
after immunoprecipitation (Ng et al., 2009). This strategy allowed
us to probe the composition of the destruction complex in Wnt-
active versus nonactive HEK293T cells. Axin1 protein is
degraded upon Wnt stimulation (Jiang et al., 2009; Kim et al.,
2008; Mao et al., 2001). We stimulated HEK293T cells with
Wnt3A-conditioned medium or control medium and monitored
Axin1 protein and cytosolic b-catenin by western blot analysis
(Figure S1A available online and Figure 1A). Of note, the over-
whelming amount of b-catenin resides in the membrane-bound
E-cadherin complex, a highly stable pool that is irrelevant to
Wnt signaling (van de Wetering et al., 2001). To increase detec-
tion sensitivity, we performed Axin1 immunoprecipitation on
whole-cell lysates prior to western blot analysis (Figures 1B
and 1C). Though cytosolic accumulation of b-catenin was
detectable as early as 30min followingWnt treatment (Figure 1A),
we first observed a significant decrease in endogenous Axin1
protein at 4 hr post-Wnt stimulation (Figures 1B, 1C, and S1A),
implying that degradation of Axin1 protein is not causal to the
initial activation of the Wnt pathway.
To extend these findings, we examined the endogenous Wnt
target genes AXIN2 (Lustig et al., 2002), CCND1 (Tetsu and Mc-
Cormick, 1999), EPHB3 (van de Wetering, M et al., 2002), TCF7
(Roose et al., 1999), and ZCCHC12 (Mahmoudi et al., 2009) by
quantitative RT-PCR in a time course experiment (Figure 1D).
Significant mRNA increases were detected from 0.5–2 hr post-
Wnt stimulation (Figure 1D), when Axin1 protein levels were still
unchanged.
Phosphorylated b-Catenin Accumulates in the Axin1
Complex in Response to Wnt
We then asked how the interaction between Axin1 and other
components of the Wnt cascade is influenced by Wnt
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Figure 1. Wnt-Induced Stabilization of b-Catenin Occurs prior to and Independently of Axin1 Degradation
HEK293T cells were stimulated with Wnt according to the indicated time points.
(A) Cytosolic b-catenin protein levels begin to accumulate 30min afterWnt stimulation, peaking at2 hr. GAPDHprotein levels were used as loading control. Note
that there is vanishingly detectable free b-catenin in cytosol in the absence of Wnt.
(B) Axin1 immunoprecipitation was performed from whole-cell lysates for detection of endogenous Axin1 level upon Wnt induction. GAPDH input was used as
input loading control.
(C) Quantitation of Axin1 protein level relative to GAPDH. Axin1 degradation becomes significant at 4 hr post-Wnt induction. Error bars represent ±SD.
(D) Wnt-induced activation of target genes CCND1, TCF7, ZCCHC12, EPHB3, and AXIN2 and, as control, ACTBwas examined in HEK293T cells by quantitative
RT-PCR at the indicated time points. Time course expression data are presented as fold induction normalized to GAPDH control in triplicate and are repre-
sentative of at least two independent experiments. Error bars represent ±SD.
See also Figure S1.stimulation. We immunoprecipitated the Axin1 complex from
HEK293T cells before and during Wnt treatment, followed by
western blotting (Figure 2A). In the absence of Wnt, Axin1 inter-
acted with GSK3 (last panel) and APC (second panel), but not
LRP6 (fourth panel). Phosphorylated LRP6 was only detected in
the Axin1 complex after Wnt stimulation (third panel) (Mao
et al., 2001; Tamai et al., 2004; Tolwinski et al., 2003). Dishevelled
3 coimmunoprecipitated with Axin1 in the absence and presence
ofWnt (fifth panel). In contrast to previous reports (Liu et al., 2005;
Logan and Nusse, 2004), we did not find a significant decrease in
binding of either APC (second panel) or GSK3b (last panel) to
Axin1 in response to Wnt stimulation. This observation was
inconsistent with models in which dissociation of the destruction
complex or modulation of Axin1 binding to GSK3b or APC
mediate functional inactivation of the destruction complex.
b-catenin coimmunoprecipitating with Axin1 was hardly
detectable in the absence of Wnt stimulation, highlighting the
dynamic nature of the b-catenin/Axin1 interaction (Figure 2,
eighth panel). Surprisingly, we found a significant Wnt-inducedincrease in b-catenin immunoprecipitating with Axin1.We further
analyzed this b-catenin pool using antibodies that specifically
recognize P-Ser45 b-catenin or P-Ser33/Ser37/Thr41 b-catenin
(Figure 2, sixth and seventh panel). Counter to prediction, we
found an increase in phosphorylated b-catenin in the Wnt-stim-
ulated Axin1 complex (Figure S2A). This finding was consistent
with a previous report noting phosphorylated b-catenin in high-
molecular-weight complexes, whereas non-phospho-b-catenin
accumulated in a monomeric form upon Wnt signaling (Maher
et al., 2010). Thus, the critical kinases CK1 and GSK3b remain
present and active within the destruction complex upon Wnt
signaling.
We also combined Axin1 immunoprecipitation with mass
spectrometry (MS) to obtain a global picture of theAxin1 complex
in HEK293T. Consistent with our IP results, we readily detected
the core components of the destruction complex (APC, GSK3b,
CK1, and b-catenin) in both Wnt-inactive and -activated cells
(Table S1). Quantitative MS using a label-free approach with
extracted ion chromatograms further confirmed a significantCell 149, 1245–1256, June 8, 2012 ª2012 Elsevier Inc. 1247
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Figure 2. Accumulation of Phosphorylated b-Catenin in Axin1-b-Catenin Destruction Complex upon Wnt Activation
(A) HEK293T cells were exposed to Wnt3A-conditioned medium or control-conditioned medium at different time points as indicated. Stimulated lysates were
subjected to immunoprecipitation using an Axin1-specific antibody and IgG as control and were subjected to SDS-PAGE followed by western blot analysis using
the indicated antibodies.
(B) Wnt-stimulated HEK293T cells with or without GSK3 inhibitor BIO treatment were subjected to Axin1 immunoprecipitation followed by western blot analysis
using the indicated antibodies.
(C) Quantitation of the amount of b-catenin phosphorylation in the Axin complex upon Wnt stimulation by comparing the ratio between phospho-b-catenin
(ser33/37/thr41) and active non-phospho-b-catenin with total b-catenin. Error bars represent ±SD.
(D) HEK293T and Ls174T cells treated with control- or Wnt-conditioned medium were subjected to Axin1 immunoprecipitation followed by western blot analysis
using the indicated antibodies.
(E) Quantitation of b-catenin phosphorylation in the Axin complex upon Wnt stimulation in HEK293T and Ls174T cells was done as described in (C).
See also Figure S2 and Tables S1 and S2.increase of b-catenin detected within the Axin complex after Wnt
stimulation. Other components (e.g., APC, GSK3b, and CK1)
remained unchanged (Figures S2C, S2D, and Table S2). Similar
observations were reported recently (Hilger and Mann, 2012).
To quantify the relative amount of phosphorylated b-catenin
bound to the Axin-b-catenin destruction complex upon Wnt
stimulation, we treated HEK293T with 6-bromoindirubin-
30-oxime (BIO), a GSK3 inhibitor. HEK293T cells, either untreated
or treated with BIO overnight, were induced to Wnt3A followed
by Axin1 immunoprecipitation. Axin-bound b-catenin was then
analyzed by Western blotting (Figure 2B). Confirming our earlier
observations, phospho-b-catenin was strongly present in the
Axin complex after Wnt induction. Importantly, BIO treatment
completely abolished b-catenin phosphorylation in the Axin
complex (Figure 2B), implying that GSK3 remained active
under Wnt stimulation. An antibody, recognizing non-phospho-
b-catenin (van Noort et al., 2002), confirmed the accumulation
of non-phospho-b-catenin in the Axin-complex after BIO treat-
ment. Quantitation of the ratio between phospho- and non-phos-
pho b-catenin relative to total b-catenin demonstrated that
80% of b-catenin bound to the Axin complex upon Wnt induc-
tion was phosphorylated (Figure 2C).
To further quantify b-catenin phosphorylation within the Axin
destruction complex, we compared the ratio of phospho- to1248 Cell 149, 1245–1256, June 8, 2012 ª2012 Elsevier Inc.non-phospho b-catenin in the presence or absence of Wnt in
HEK293T and in Ls174T colorectal cancer (CRC) cells (Fig-
ure 2D). In Ls174T, b-catenin is homozygously mutated at
Ser45 and cannot be phosphorylated by CKIa and consequently
by GSK3. b-catenin is thus not recognized by the phospho-
b-catenin antibody in these cells. As expected, phospho-
b-catenin was detected in HEK293T after Wnt induction, but
not in Ls174T cells, whereas non-phospho b-catenin was
present in Ls174T cells only (Figure 2D, lanes 4 and 8). Confirm-
ing our results using BIO treatment of HEK293T cells (Figure 2C),
quantitation of the ratio between phospho- and non-phospho
b-catenin in HEK293T versus Ls174T cells revealed that 80%
of b-catenin within the destruction complex was phosphorylated
in HEK293T cells (Figure 2E). Taken together, these results imply
that Wnt stimulation does not affect the destruction complex
kinases GSK3 or CK1 but, rather, causes accumulation of phos-
pho-b-catenin in the Axin-complex.
Wnt Stimulation Abrogates Ubiquitination of
Phosphorylated b-Catenin
To determine whether the b-catenin pool bound to Axin1 is
subject to ubiquitination and degradation within the complex,
we treated HEK293T cells with a combination of Wnt and
the proteasome inhibitor MG132. This compound blocks
proteasomal degradation of ubiquitinated proteins. First, we
examined whether treatment with proteasome inhibitor allowed
detection of ubiquitinated Axin1-bound b-catenin in non-Wnt
stimulated HEK293T cells. We immunoprecipitated Axin1 from
lysates of MG132-untreated or -treated cells and probed for
the association of S33/S37/T41 phosphorylated b-catenin with
Axin1 (Figure S3A). If ubiquitination and degradation of b-catenin
occurs within the destruction complex, we should detect the
ubiquitinated forms of phosphorylated b-catenin upon Axin
pull-down. Indeed, we readily observed ubiquitinated, phos-
phorylated b-catenin in immunoprecipitated Axin1 complexes
after MG132 treatment (Figure S3A). This implied that b-catenin
is not only phosphorylated, but also ubiquitinated and degraded
within the destruction complex, suggesting a proteasome-
dependent mechanism for complex regeneration. In support of
this notion, we detected a number of proteasome complex
subunits in our Axin1 immunoprecipitation/MS experiment in
HEK293T cells (Figure S1B and Table S1). Independently,
tandem-affinity purification of SBP-HA-CBP-tagged Axin
coupled to mass spectrometry has identified the ubiquitin
protease USP34 as an Axin1-interacting protein (Lui et al.,
2011). These data imply that the phosphorylated and ubiquiti-
nated form of b-catenin is removed from the Axin1 complex by
proteasomal degradation, thus recycling the destruction
complex.
As additional evidence, we performed a time course experi-
ment forMG132 treatment, followed by Axin IP andwestern blot-
ting for ubiquitinated phospho-b-catenin (Figure 3A). We
reasoned that, if our hypothesis was correct, direct blockage of
proteasomal degradation within the Axin1-complex by MG132
treatment should cause an immediate phospho-b-catenin accu-
mulation within the Axin complex, with faster kinetics than the
accumulation induced by Wnt (Figure 2A). Indeed, we found
that, even after only 0.5 hr of MG132 treatment, phospho-
b-catenin occurred in the Axin complex (Figure 3A). Ubiquitina-
tion of b-catenin was confirmed using an anti-ubiquitin antibody
(Figure S3B). Cells remained healthy, as 7 hr of MG132 in the
absence of Wnt readily activated Wnt/TCF-driven transcription
as determined by qRT-PCR for Wnt target gene expression and
by TOPFlash luciferase assay (Figures 3B, S3E, S3F).
To test the effect of Wnt on ubiquitination of b-catenin within
the Axin complex, we immunoprecipitated Axin1 from lysates
treated with either MG132 alone or combined with Wnt. There
was a much stronger presence of phosphorylated b-catenin
that coimmunoprecipitated with Axin1 in MG132-treated cells
without Wnt than in cells treated with MG132 with Wnt (Fig-
ure 3C). Of note, the polyubiquitination of phospho-b-catenin is
shown by multiple band shifts of 8 kDa (Figure 3D, arrows).
This result suggested that Wnt stimulation interferes with ubiqui-
tination of phosphorylated b-catenin within the destruction
complex.
To document the ubiquitination state of phospho-b-catenin
within the destruction complex, we overexpressed His-tagged
ubiquitin in HEK293T cells 12 hr prior to treatment with MG132
and Wnt. Antibodies specific for Axin1, b-catenin, or control iso-
type-matched IgG were used to immunoprecipitate the specific
complexes (Figure 3E). The immunoprecipitated complexes
were washed and eluted followed by a His pull-down assay.The His pull-down samples were analyzed by western blotting
using an antibody specific for b-catenin (Figure 3F). We found
significantly less ubiquitinated b-catenin in Wnt-treated cells
than in untreated samples (Figure 3F, lanes 7 and 8). Ubiquiti-
nated b-catenin occurred only in Axin1 complexes when cells
were treated with onlyMG132 and not withMG132 andWnt (Fig-
ure 3F, lanes 5 and 6). These data demonstrated that Wnt stim-
ulation interferes with ubiquitination of phosphorylated b-catenin
within the destruction complex.
We then examined whether Wnt stimulation has an effect on
b-TrCP, the E3 ligase that ubiquitinates b-catenin (Aberle et al.,
1997; Kitagawa et al., 1999). As shown in Figures 3G and 3H,
whereas b-TrCP coimmunoprecipitated with both b-catenin (Fig-
ure 3G, lane 5) and Axin1 (Figure 3H, lane 5) in the presence of
MG132 in non-Wnt-treated cells, Wnt treatment abrogated the
b-TrCP interaction with b-catenin (Figure 3G, lane 6) and Axin1
(Figure 3H, lane 6). The dissociation of b-TrCP upon Wnt stimu-
lation was seen with two b-TrCP antibodies (Figures 3H and
S3C). As expected, b-TrCP also dissociated from exogenously
expressed Flag-tagged b-catenin upon Wnt stimulation (Fig-
ure S3D). Wnt-driven suppression of b-catenin ubiquitination
and b-TrCP dissociation from the complex was confirmed using
an Axin-specific monoclonal antibody (A6) recognizing a distinct
epitope (Figure S4A) as well as with Flag-tagged human Axin1
(Figure S4B).
Wnt-Induced Accumulation of Phosphorylated
b-Catenin within the Axin1 Complex in Primary Tissue
The small intestinal epithelium is arguably the best described
model for mammalian Wnt signaling. Signaling is active in all
crypt cells and inactive in all villus cells (Reya and Clevers,
2005) and can be visualized by b-catenin nuclear localization
or by Wnt target genes such as Axin2 (Figure 4A). We performed
endogenous Axin1 IP on freshly isolated crypts and villi. Consis-
tent with the HEK293T data, Axin1 complex interacted with
phospho-Lrp6 in crypt cells, but not villus cells (Figure 4B). The
increased presence of phospho-b-catenin within the Axin1
complex was detected in crypt, but not villus cells. We confirmed
this in cultured intestinal organoids (Sato et al., 2009). This
culture requires R-spondin (Figure S5A) to enhance Wnt signals
through its receptors Lgr4 and Lgr5 (de Lau et al., 2011). We
treated the organoids with or without R-spondin and Wnt3A
medium for 4 hr followed by Axin1 immunoprecipitation. This
confirmed the phospho-Lrp6/axin1 interaction as well as the
accumulation of b-catenin in the Axin1 complex in the presence
of R-spondin and Wnt3A medium (Figure S5B). The new Wnt
regulatory model for the destruction complex is shown in
Figure 4C.
A recent report proposes that sequestration of GSK3 into mul-
tivesicular bodies controls its activity during Wnt signaling (Tael-
man et al., 2010). We have previously demonstrated different
GSK3 pools; only 3%–5% of endogenous cellular GSK3 resides
in the destruction complex (Ng et al., 2009). Our current findings
do not support the GSK3 sequestration model during initial Wnt
activation. We examined the effect of Wnt on b-TrCP interaction
with the Axin1 complex 1 hr poststimulation in HEK293T cells.
We detected significant dissociation of b-TrCP from Axin1 at
this early time point (Figures 5A and 5B). Interaction of Axin1Cell 149, 1245–1256, June 8, 2012 ª2012 Elsevier Inc. 1249
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Figure 3. Wnt Stimulation Abrogates Ubiquitination of Phosphorylated b-Catenin and Disrupting the Interaction of b-TrCP with the Axin1-
b-Catenin Destruction Complex
(A) HEK293T cells were treated with or without proteasome inhibitor MG132 at indicated time points. Samples were immunoprecipitated with Axin1 antibody
followed by western blot analysis using the indicated antibodies.
(B) qRT-PCR results of indicated Wnt target genes with control or MG132 treatment after 7 hr. Error bars represent SD from three independent experiments.
*p < 0.001.
(C) HEK293T cells were treated with proteasome inhibitor MG132 together with Wnt3A- or control-conditioned medium for 4 hr. Treated cells were collected,
lysed, and used for Axin1 immunoprecipitation, followed by western blot analysis using the indicated antibodies. Arrows indicate detection of polyubiquitinated
phospho-b-catenin with an 8 kDa shift.
(D) Enlargement of anti-phospho-b-catenin (Ser33/Ser37/T41) blot from (C) for better resolution.
(E and F) HEK293T cells were transfected with His-tagged ubiquitin. After 12 hr, cells were treated with proteasome inhibitor MG132 together with Wnt3A- or
control-conditionedmedium for 4 hr. Cell lysates were then used for immunoprecipitation with antibodies specific for Axin1, b-catenin, or control IgG as indicated
(E). Axin1 and b-catenin complexes were eluted and used in His pull-down assays. Samples were separated by SDS-PAGE and analyzed by western blotting with
anti b-catenin antibody (F).
(G and H) HEK293T cells treated with MG132 together with Wnt3A or control-conditioned medium for 4 hr were lysed and immunoprecipitated with an antibody
against b-catenin (G) or Axin1 (H). Immunoprecipitated complexes were analyzed by western blotting using antibodies directed against b-TrCP, b-catenin, Axin1,
and GAPDH as control as indicated.
See also Figures S3 and S4.
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Figure 4. Wnt-Induced b-Catenin Phosphorylation
within the Destruction Complex Is Confirmed in
Primary Tissues
(A) Schematic representation of small intestine showing
Wnt signal is ‘‘on’’ in crypt and ‘‘off’’ in villus compartment.
Immunohistochemical staining showing b-catenin is
nuclei-localized in the crypts. The Wnt target gene AXIN2
mRNA is also expressed at the bottomcrypts, as shown by
in situ hybridization.
(B) Axin1 complexes were immunoprecipitated from iso-
lated crypts and villi fractions followed by western blot
analysis using the indicated antibodies.
(C) Schematic diagram showing a novel regulatory model
of Wnt/b-catenin signaling. Refer to the text for details.
See also Figure S5.with phospho-Lrp6 was also detected (Figure 5A). We then
analyzed the sequestration of the Axin1 destruction complex
into MVB at early Wnt induction time points (1 and 4 hr post-
Wnt stimulation) by studying colocalization with LysoTracker,
a dye marking MVB and lysosomes. We did not detect colocal-
ization of endogenous b-catenin (Figures 5C–5E) or GSK3b
(Figures 5F–5H) with LysoTracker after 1 or 4 hr. We further
analyzed the localization of Axin1 by overexpressing Axin1-
YFP in the cells. Axin1-YFP puncta were detected in the cytosol
(Figures 5I–5K). However, no colocalization of Axin1 with Lyso-
Tracker was observed even after 4 hr. We therefore concluded
that b-TrCP dissociation from the destruction complex is the
immediate molecular response following Wnt stimulation. Our
data do not exclude that sequestration of the destruction
complex in MVB may occur as a later event.
Axin1 Complex Remains Compositionally Intact in APC
and b-Catenin Mutant Colon Cancer Cells
Activating mutations of Wnt pathway components constitute the
gatekeeper event in human colorectal cancer (Fodde and Bra-
bletz, 2007). The data in Figure 2D suggested that the Axin
complex remains intact upon mutational Wnt activation in
CRC. We examined the Axin1 complex in various CRC cell lines
in which the Wnt pathway is locked in the ‘‘on’’ state. We immu-
noprecipitated Axin1 from Ls174T (homozygous activating
b-catenin mutation; WT APC), HCT116 (Ser45 deletion in one
b-catenin allele and oneWT allele; WT APC) and from DLD1 cells
(truncated APC; WT b-catenin). We then probed the Axin1-
immunoprecipitated complexes for components of the destruc-
tion complex (Figure 6A). In all CRCs, the destruction complex
contained the core components GSK3b and b-catenin despiteCell 149, 1the constitutive activity of the Wnt pathway.
More interestingly, the destruction complex of
DLD1 cells contained themutationally truncated
APC, lacking the Axin-binding SAMPmotifs and
most b-catenin 20 aa repeats (Miyoshi et al.,
1992; Nagase and Nakamura, 1993). We
excluded the possibility that Axin1 interacts
with APC and b-catenin in distinct subcom-
plexes (Figures S6A and S6B). Does GSK3 still
phosphorylate b-catenin within the Axin1complex in these APC-mutated CRCs? In HCT116, there
remains one WT allele of b-catenin. Indeed, phospho-b-catenin
was readily detectable in the Axin1 complex. In DLD1, a
P-Ser33/Ser37/Thr41 b-catenin coimmunoprecipitated with
Axin1 (Figures 6A and S6C). Thus, disruption of the interaction
between APC and b-catenin is not the mechanism of tumorigen-
esis caused by APC mutations. Rather, these observations
suggested that the Axin1 complex may be saturated by phos-
pho-b-catenin in CRCs due to improper function of APC.
Unlike the situation in exogenous Wnt-activated HEK293T
cells, Lrp6 did not coimmunoprecipitate with Axin1 in CRCs (Fig-
ure 6A, top). We hypothesized that the upstream pathway in the
Wnt cascade may be functionally intact and can further be
induced by Wnt treatment. Consistent with this hypothesis, all
three CRCs showed Wnt receptor activation upon Wnt stimula-
tion, as read out by Lrp6 phosphorylation (Figure 6B). HCT116
could be further activated by exogenous Wnt based on TOP/
Flash luciferase assays (Figure 6C). This can be explained by
the fact that HCT116 cells retain one wild-type b-catenin allele.
Failure of Axin-Bound b-Catenin Ubiquitination
in APC-Truncated Cell Lines
It is commonly believed that APC truncation in CRCs causes
dissociation of the destruction complex because of the loss of
the 20 aa repeat regions that bind b-catenin (Munemitsu et al.,
1995) and/or the SAMP repeats that bind Axin (Behrens et al.,
1998). Contrasting with this notion, we find that the Axin complex
remains intact in CRCs. This prompted us to study whether APC
truncation would rather affect b-catenin ubiquitination.
Re-expression of the central region of APC is sufficient for Wnt
pathway regulation (Munemitsu et al., 1995). We therefore245–1256, June 8, 2012 ª2012 Elsevier Inc. 1251
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Figure 5. b-TrCP Dissociation from the Complex Is
the Immediate Response of Wnt Stimulation, prior
to Sequestration of the Complex to Multivesicular
Endosomes
(A) HEK293T cells were treated with proteasome inhibitor
MG132 together with Wnt3A- or control-conditioned
medium for 1 hr. Treated cells were collected, lysed, and
used for Axin1 immunoprecipitation, followed by western
blot analysis with anti-phospho-Lrp6, Axin, and b-TrCP
antibodies.
(B) Quantitation of b-TrCP level normalized to Axin1 after
control or Wnt3A medium treatment for 1 hr from (A). Error
bars represent SD from three independent experiments.
Error bars represent ±SD.
(C–K) HEK293T cells were treatedwith control- (C, F, and I)
or Wnt3A-conditioned medium for 1 (D, G, and J) and 4 hr
(E, H, and K). Co-immunostaining of Wnt components
(green) b-catenin (C–E), GSK3b (F–H), and Axin1-YFP (I–K)
with LysoTracker (red) was performed after Wnt treatment
at different time points. Colocalization of b-catenin and
LysoTracker is indicated by white arrow.cloned this central region (1265–2060 amino acids) containing
the 20 aa repeats and the SAMP motifs (Figure 7A). TOP/Flash
luciferase arrays confirmed that this central region of APC could
significantly suppress the downstream b-catenin/TCF transcrip-
tion in both SW480 (Figure 7B) and DLD1 cells (Figure S7A) to
a level comparable to full-length APC.
To examine the b-catenin ubiquitination state in these two
APC truncated cell lines, we pretreated the cells with MG132
for 4 hr followed by endogenous Axin1 immunoprecipitation.
Western blot analysis revealed that b-catenin was present in
the Axin1 complex in both SW480 and DLD1 cells (Figures 7C
and S7B, lane3). Strikingly, b-catenin ubiquitination was readily
detectable in the Axin1-complex after reintroducing APC 1265–
2060 (Figures 7C and S7B, lane 4). Our data demonstrate that
APC truncations in CRCs activate Wnt signal by impairing
b-catenin ubiquitination within the destruction complex, thereby
saturating the complex, as Wnt treatment does to normal cells.
DISCUSSION
In the current study, we have not used overexpression analyses
but, for the first time, study the endogenous Axin complex. We
make a number of observations that are not compatible with ex-
isting models of Wnt signal transduction. Specifically: (1) The
composition of the Axin complex does not change upon Wnt1252 Cell 149, 1245–1256, June 8, 2012 ª2012 Elsevier Inc.signaling. (2) The activities of the kinases
(GSK3/CKI) are not inhibited upon Wnt
signaling. Rather, a phosphorylated form of
b-catenin accumulates in the intact destruction
complex upon Wnt signaling. (3) The E3 ligase
b-TrCP acts within the intact destruction
complex. (4) It has been unknown how b-cate-
nin, once targeted for destruction, is removed
from the complex. We now show that removal
of b-catenin from the intact complex is executed
by the proteasome upon ubiquitination. (5) Incontrast to current belief, the Axin complex remains composi-
tionally intact in APC mutant colorectal cancer. Again, it is the
failure of b-catenin ubiquitination that is the principle biochem-
ical activating event.
Our current data thus support an alternate Wnt-induced regu-
latory model for the destruction complex, as shown in Figure 4C.
In the absence of Wnt stimulation, b-catenin is sequentially
phosphorylated within the destruction complex by the serine/
threonine kinases CK1 and GSK3a/b. Phosphorylated b-catenin
is then recognized by b-TrCP, a component of the E3 ubiquitin
ligase complex, and ubiquitinated (Ub) within the destruction
complex. Subsequently, ubiquitinated b-catenin is rapidly
degraded by the proteasome. The removal of b-catenin from
the destruction complex is accomplished simply by direct degra-
dation by the proteasome. This step recycles the destruction
complex for another round of b-catenin degradation. We show
that Wnt receptor-ligand interaction leaves the destruction
complex compositionally unchanged and does not affect the
activity of its kinases. The only change that we observe is the
association of Axin1 with phosphorylated Lrp6 and the dissocia-
tion of b-TrCP. Indeed, phosphorylated b-catenin—still bound to
the Axin1 complex—is no longer ubiquitinated and degraded. It
saturates and thus effectively inactivates the Axin1 complex. We
have previously reported that only b-catenin that is newly synthe-
sized after initiation of the Wnt signal is signaling competent
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Figure 6. The Axin1-b-Catenin Destruction Complex Remains
Compositionally Intact despite ConstitutiveWnt Signaling in Various
Colorectal Cancer Cell Lines
(A) Cell lysates from colorectal cancer cell lines Ls174T, HCT116, and DLD-1,
as indicated, were immunoprecipitated with a specific antibody directed
against endogenous Axin1 and IgG as a negative control. The immunopre-
cipitated complex was analyzed by western blotting using antibodies directed
against Lrp6, Axin1, b-catenin, phosphorylated b-catenin, b-TrCP, APC, and
GSK3b and, as a negative control, GAPDH.DAPC indicates the truncated form
of APC expressed in DLD-1 (140 KD) cells.
(B) HEK293T cells together with threeCRCs, Ls174T, HCT116, andDLD1 cells,
were treated with control or Wnt3A medium for 4 hr followed by western blot
analysis to probe for Lrp6 phosphorylation.
(C) Relative TOP/FOP activities were shown after control (white bars) or Wnt3A
(black bars) treatment to the three CRCs. Error bars represent SD from three
independent experiments.*p < 0.001.
See also Figure S6.(Staal et al., 2002). This notion is in agreement with our current
model, which predicts that newly synthesized, nonphosphory-
lated b-catenin will be stable in a free cytosolic form once the
destruction complex is saturated. It can then translocate to the
nucleus to associate with TCF and activate the Wnt transcrip-
tional program.
Comparing these molecular events to those resulting from
mutations in b-catenin and APC in CRC reveals mechanistic
differences in these two ‘‘Wnt on’’ systems. In HEK293T, Wnt
stimulation leads to a temporary inactivation-by-saturation of
the destruction complex, followed by degradation of the
Axin1 scaffold itself. By contrast, the destruction complex is
compositionally intact and stable in all CRC lines examined.Contrary to common belief, truncated APC remains present
within the Axin1 complex in APC mutant CRC cells. Our data
support a model in which mutations in Wnt pathway compo-
nents in CRC cause the Axin1 complex to be locked in
a compositionally intact but functionally inactive form, leading
to aberrant cytoplasmic accumulation and nuclear localization
of b-catenin.
What is the essential role played by APC during the b-catenin
degradation/elimination process?Our observations indicate that
APC protein function is most likely required at a step after
b-catenin phosphorylation. APC was reported to act as a
‘‘ratchet’’ to remove phosphorylated b-catenin from Axin for
ubiquitination, making Axin available for further rounds of
b-catenin phosphorylation (Kimelman and Xu, 2006; Xing et al.,
2003). We do not confirm this observation. Rather, we observe
that removal of ubiquitinated b-catenin from the Axin1 complex
requires functional proteasomes. Interestingly, it has recently
been shown that b-TrCP can only interact with b-catenin in the
presence of ectopically expressed wild-type APC in three
APC-truncated cell lines. This study lends support to the notion
that APC may function by mediating b-catenin’s ubiquitination
by b-TrCP (Su et al., 2008). Indeed, our current data prove that
APC truncation results in failure of b-catenin ubiquitination within
the Axin destruction complex.
EXPERIMENTAL PROCEDURES
Antibodies
APC (Calbiochem), Dishevelled3 (Santa Cruz), GSK3b (Cell Signaling), phos-
pho-LRP6 (S1490, Cell Signaling), LRP6 (Cell Signaling), phospho-b-catenin
S45 (Cell Signaling), phospho-b-catenin S33/S37/T41 (Cell Signaling), b-cate-
nin (BD Transduction), active-b-catenin (Millipore, 8E7), b-TrCP (ITK Diagnos-
tics BV and Cell Signaling), ubiquitin (Millipore, FK2), and GAPDH (Abcam)
were used in immunoprecipitations or Western blot analysis.
Cell Culture
HEK293T, DLD-1, HCT116, and Ls174T cells were maintained in RPMI 1640
(Invitrogen) supplemented with 5% fetal calf serum (FCS). Wnt3A-producing
L cells (kind gift from R. Nusse) or control L cells were cultured according to
the manufacturer’s instructions (ATCC).
Cell Fractionation
HEK293T cells were stimulated with Wnt3A-conditioned medium or control-
conditioned medium as indicated. Cells were washed and collected in ice-
cold PBS. Cell pellets were then resuspended in hypotonic lysis buffer
(10 mM KCl, 10 mM Tris [pH 7.5], and 2 mM EDTA) containing protease inhib-
itor and phosphatase inhibitor cocktail tablets. Cell suspensions were incu-
bated on ice for 30 min and dounced multiple times. Lysis of cells was
controlled by checking under the microscope. Nuclear proteins, including
the unlysed cells, were pelleted by spinning at 2,000 rpm for 2 min at 4C
centrifugation. The supernatant that contained both cytoplasm andmembrane
proteins was then centrifuged at 14,000 rpm for 30min at 4C. The supernatant
was collected and analyzed further by SDS-PAGE followed by western
blotting.
Immunoprecipitation
At 80% confluency, HEK293T cells were treated with either Wnt3A or
control-conditioned medium in the absence or presence of 10 mM MG132
as indicated. For GSK3 inhibitor BIO assay, 5 mM BIO was added to the
cells 16 hr prior to Wnt induction. HEK293T, Ls174T, DLD-1, and SW480
cells were washed and collected with cold PBS, lysed in cold lysis buffer
containing 150 mM NaCl, 30 mM Tris (pH 7.5), 1 mM EDTA, 1% Triton
X-100, 10% Glycerol, 0.1 mM PMSF, 0.5 mM DTT, protease inhibitorCell 149, 1245–1256, June 8, 2012 ª2012 Elsevier Inc. 1253
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Figure 7. APC Truncation Impairs b-Catenin Ubiq-
uitination within the Axin Complex
(A) Schematic representations of wild-type full-length and
the central region (1265–2060 amino acids) of APC.
(B) Relative TOP/FOP activities of the APC truncated cell
line SW480 was shown after transfecting empty vector,
full-length, or central region of APC plasmids. Error bars
represent ± SD.
(C) Axin1 complexes were immunoprecipitated from
SW480 cells with or without APC transfection and were
analyzed by western blotting using the indicated anti-
bodies.
See also Figure S7.cocktail tablets (EDTA-free) (Roche), and phosphatase inhibitor cocktail
tablets (Roche). After clarification by centrifugation (14,000 rpm for 30 min
at 4C), the cellular lysates were precleared with IgG-agarose beads (Sigma)
for at least 6 hr at 4C. Immunoprecipitation of endogenous complexes was
carried out by incubating the cellular lysates with anti-Axin1 antibody,
mouse IgG, or b-catenin antibody (BD Transductions) immobilized on
Protein G PLUS-Agarose beads (Santa Cruz Biotechnology) at 4C over-
night. Immunocomplexes were washed with cold lysis buffer six times, re-
suspended in SDS sample buffer, and subjected to SDS-PAGE and western
blot analysis.
Immunostaining Assay
HEK293T were grown on 12-well coverslips in 12-well plates precoated with
poly-L-lysin (Sigma), fixed with 4% paraformaldehyde (PFA) for 15 min, and
permeabilized by 0.2%Triton X-100 in PBS for 10 min. Cells were blocked
with 5%goat serum and 0.5%BSA in PBS for 1 hr and then primary antibodies
overnight at 4C. Cells were washed three times PBS followed by secondary
antibodies incubation at room temperature for 1 hr. Coverslips were washed
another three times with PBS and were then mounted with Vectashield with
DAPI (Vector Lab). For LysoTracker staining, live cells were treated with
1:1,000 diluted LysoTracker Red DND-99 (Invitrogen) for 1 hr at 37C prior
to 4%PFA fixation.
In Vivo and Ex Vivo Wnt Induction Using Mouse Small Intestines
Intestinal crypts and villi fractions were isolated as previously described
(Mahmoudi et al., 2009) followed by Axin1 immunoprecipitation. Wild-type
isolated crypts were cultured into organoids according to the protocols in-
vented by our group (Sato et al., 2009). Organoids were pretreated with or
without Rspondin and Wnt-conditioned medium for 4 hr followed by Axin1
immunoprecipitation.
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